PEPROTECH EC LTD
Get an alert when PEPROTECH EC LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-07-16 (in 2mo)
Last made up 2025-07-02
Watchouts
Cash
£31K
-50.5% lowest in 3 filed years
Net assets
£14M
+7.8% highest in 3 filed years
Employees
21
-32.3% lowest in 3 filed years
Profit before tax
£984K
-43.2% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
Post year end Peprotech EC Ltd is due to be made dormant with trading of the company discontinuing. The assets of Peprotech EC Ltd will be hived up into another Thermo Fisher Scientific Inc company, Life Technologies Limited. As a result of this, Peprotech EC Ltd is not considered to be a going concern.
Net assets
3-year trend · vs Consumer Discretionary median
Accounts
3-year trend · latest reflected 2024-12-31
| Metric | Trend | 2022-10-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Turnover | — | £18,653,378 | £10,465,214 | |
| Operating profit | — | £1,306,933 | £458,507 | |
| Profit before tax | £978,810 | £1,732,021 | £984,065 | |
| Net profit | £795,354 | £1,727,277 | £1,004,024 | |
| Cash | £8,847,458 | £61,732 | £30,586 | |
| Total assets less current liabilities | £11,076,265 | £12,808,111 | £13,800,713 | |
| Net assets | £11,069,412 | £12,796,689 | £13,800,713 | |
| Equity | £11,069,412 | £12,796,689 | £13,800,713 | |
| Average employees | 35 | 31 | 21 | |
| Wages | £4,701,683 | £1,909,056 | £1,569,080 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2022-10-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|
| Operating margin | — | 7.0% | 4.4% | |
| Net margin | — | 9.3% | 9.6% | |
| Return on capital employed | — | 10.2% | 3.3% | |
| Current ratio | — | 8.94x | 14.19x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Mitchell Charlesworth (Audit) Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“Post year end Peprotech EC Ltd is due to be made dormant with trading of the company discontinuing. The assets of Peprotech EC Ltd will be hived up into another Thermo Fisher Scientific Inc company, Life Technologies Limited. As a result of this, Peprotech EC Ltd is not considered to be a going concern.”
Group structure
- PEPROTECH EC LTD · parent
- PeproTech France SARL 100%
- PeproTech Gmbh 100%
Significant events
- “The company is currently monitoring the potential impact of the conflict between Russia and Ukraine on the company The directors and senior leadership team believe that the Company currently do not have direct exposure to Ukraine or Russia. Furthermore, the directors continue to monitor the impact on the Company of the overall economic uncertainty and negative impacts on the global economic and major financial markets.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 9 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2022-10-31 | — | — |
| AHMED, Syed Waqas | Director | 2022-10-31 | Nov 1979 | British |
| GREEN, Georgina Adams | Director | 2024-04-18 | Mar 1970 | British |
| SMITH, Anthony Hugh | Director | 2022-10-31 | May 1962 | American |
| STARR, Alison Jane | Director | 2024-04-18 | Jan 1977 | British |
Show 9 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GOLDMAN, Robert | Secretary | 1993-07-02 | 2022-10-31 |
| GREGG, Rhona | Secretary | 2022-10-31 | 2026-03-31 |
| CCS SECRETARIES LIMITED | Corporate Nominee Secretary | 1993-07-02 | 1993-07-02 |
| CAMERON, Euan Daney Ross | Director | 2022-10-31 | 2023-01-24 |
| CASCELLA, Christopher Robert | Director | 2023-09-18 | 2024-08-09 |
| NORMAN, David John | Director | 2022-10-31 | 2024-04-18 |
| SLIGHT, Anna | Director | 1994-07-31 | 2022-10-31 |
| STABINSKY, Michelle | Director | 1993-07-02 | 1994-07-31 |
| CCS DIRECTORS LIMITED | Corporate Nominee Director | 1993-07-02 | 1993-07-02 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Thermo Fisher Scientific Inc. | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-12-30 | Active |
| Ms Zipora Stabinsky | Individual | Voting 25–50%, Appoints directors | 2016-10-31 | Ceased 2021-12-30 |
| Mr Robert Goldman | Individual | Voting 25–50%, Appoints directors | 2016-04-06 | Ceased 2021-12-30 |
| Ms Andrea Devereux | Individual | Voting 25–50%, Appoints directors | 2016-04-06 | Ceased 2021-12-30 |
| Ms Zipora Stabinsky | Individual | Shares 25–50%, Voting 25–50%, Appoints directors | 2016-04-06 | Ceased 2017-06-01 |
Filing timeline
Last 20 of 118 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-07-28 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-01 | TM02 | officers | Termination secretary company with name termination date | |
| 2025-09-25 | AA | accounts | Accounts with accounts type full | |
| 2025-07-28 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2025-07-28 | SH20 | capital | Legacy | |
| 2025-07-28 | CAP-SS | insolvency | Legacy | |
| 2025-07-28 | RESOLUTIONS | resolution | Resolution | |
| 2025-07-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-06-30 | TM01 | officers | Termination director company with name termination date | |
| 2024-07-03 | AA | accounts | Accounts with accounts type full | |
| 2024-07-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-23 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-19 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-19 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-13 | AA01 | accounts | Change account reference date company current extended | |
| 2023-09-06 | AA | accounts | Accounts with accounts type full | |
| 2023-07-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-01-25 | TM01 | officers | Termination director company with name termination date | |
| 2022-11-21 | AD01 | address | Change registered office address company with date old address new address | |
| 2022-11-02 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 8
- Capital events
- 2
- Officers appointed
- 0
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-43.9%
£18,653,378 £10,465,214
-
Cash
-50.5%
£61,732 £30,586
lowest in 3 filed years
-
Net assets
+7.8%
£12,796,689 £13,800,713
highest in 3 filed years
-
Employees
-32.3%
31 21
lowest in 3 filed years
-
Operating profit
-64.9%
£1,306,933 £458,507
-
Profit before tax
-43.2%
£1,732,021 £984,065
-
Wages
-17.8%
£1,909,056 £1,569,080
lowest in 3 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers